RANOLAZINE vs RAVULIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RANOLAZINE vs RAVULIZUMAB: Safety Overview
| Metric | RANOLAZINE | RAVULIZUMAB |
|---|---|---|
| Total FAERS Reports | 9,522 | 118 |
| Deaths Reported | 1,048 | 11 |
| Death Rate | 11.0% | 9.3% |
| Hospitalizations | 3,367 | 89 |
| Average Patient Age | 70.4 yrs | 48.4 yrs |
| % Female Patients | 42.0% | 56.3% |
| FDA Approval Date | Apr 15, 2025 | N/A |
| Manufacturer | AvKARE | Alexion Pharmaceuticals Inc. |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Discontinued | N/A |